www.fdanews.com/articles/123984-doubts-build-on-glaxo-8217-s-anti-aging-drugs
Doubts Build on Glaxo’s Anti-Aging Drugs
January 26, 2010
GlaxoSmithKline shocked the pharmaceutical industry in 2008 when it dropped $720 million
to buy Sirtris Pharmaceuticals, a biotechnology company working on drugs based on resveratrol, a chemical in red wine thought to combat the effects of
aging.
Forbes
Forbes